Rachel Frank
Investor Relations Contact chez KINIKSA PHARMACEUTICALS, LTD.
Provenance du réseau au premier degré de Rachel Frank
| Entité | Type d'entité | Industrie | |
|---|---|---|---|
| Public Company | Pharmaceuticals: Major | 18 | |
Stern Investor Relations, Inc.
 Stern Investor Relations, Inc. Investment ManagersFinance Stern Investor Relations, Inc. provides investor relations services to healthcare and biotechnology companies. The company was founded in 2009 and is headquartered in New York, NY.
12
| Subsidiary | Investment Managers | 12 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Rachel Frank via son réseau personnel
| Société | Secteur | Personnes liées | Poste principal |
|---|---|---|---|
Kiniksa Pharmaceuticals Corp.
 Kiniksa Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Part of Kiniksa Pharmaceuticals Ltd., Kiniksa Pharmaceuticals Corp. is a clinical-stage biopharmaceutical company that develops and commercializes therapeutic medicines for patients suffering from debilitating diseases. The company is based in Lexington, MA. The CEO of the company is Sanj K. Patel. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member Director/Board Member Chief Executive Officer Director of Finance/CFO | |
| GENOMIC HEALTH, INC. | Medical Specialties | Director/Board Member Chief Executive Officer Director of Finance/CFO | |
| University of Pennsylvania | College/University | Doctorate Degree Corporate Officer/Principal Undergraduate Degree | |
| Stanford University | College/University | Doctorate Degree Undergraduate Degree Doctorate Degree | |
| KYMERA THERAPEUTICS, INC. | Biotechnology | Director/Board Member Investor Relations Contact | |
| TALIS BIOMEDICAL CORPORATION | Medical Specialties | Chairman Director/Board Member | |
| KODIAK SCIENCES INC. | Biotechnology | Director/Board Member Director/Board Member | |
| ALEXION PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal | |
| PFIZER, INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Medical Specialties | Corporate Officer/Principal General Counsel | |
Baker Bros. Advisors LP
 Baker Bros. Advisors LP Investment ManagersFinance Baker Bros. Advisors LP (BBA) is an independent, SEC-registered investment advisor and hedge fund manager headquartered in New York City. The firm was founded by Julian Baker and Felix Baker in 2000 and do-business-as Baker Brothers Investments. BBA serves as a discretionary investment advisor to pooled investment vehicles operating as private investment funds and to a managed account. | Investment Managers | Founder Portfolio Manager-Equities | |
| BIOCRYST PHARMACEUTICALS, INC. | Biotechnology | Director/Board Member Director/Board Member | |
Ardea Biosciences, Inc.
 Ardea Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Ardea Biosciences, Inc. is a biotechnology company which is focused on the development of small-molecule therapeutics for the treatment of serious diseases. The company was founded in January 1994 and is headquartered in Wilmington, DE. | Pharmaceuticals: Major | Director/Board Member Founder | |
Genomic Life, Inc.
 Genomic Life, Inc. Medical/Nursing ServicesHealth Services Wamberg Genomic Advisors, Inc. engages in the provision of genomic-based programs and services. It offers a comprehensive cancer support program that provide an individual and their family with the dedicated resources, technology, and genetic testing needed to navigate cancer while improving chances of survival. The company was founded in 2017 and is headquartered in San Diego, CA. | Medical/Nursing Services | Director/Board Member Director of Finance/CFO | |
| University of Massachusetts | College/University | Undergraduate Degree | |
| VOYAGER THERAPEUTICS, INC. | Biotechnology | Investor Relations Contact | |
| SAGE THERAPEUTICS, INC. | Pharmaceuticals: Major | Investor Relations Contact | |
| SYROS PHARMACEUTICALS, INC. | Biotechnology | Director/Board Member | |
| Harvard Extension School | College/University | Graduate Degree | |
National Investor Relations Institute
 National Investor Relations Institute Miscellaneous Commercial ServicesCommercial Services National Investor Relations Institute operates as an association of corporate officers and investor relations consultants responsible for communication among corporate management, shareholders, securities analysts and other financial community constituents. The company was founded by DeWitt C. Morrill in 1969 and is headquartered in Alexandria, VA. | Miscellaneous Commercial Services | Director/Board Member | |
| Ealing Hammersmith & West London College | College/University | Graduate Degree | |
| INTERCEPT PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member | |
| DYNAVAX TECHNOLOGIES CORPORATION | Biotechnology | Public Communications Contact | |
| NEON THERAPEUTICS, INC. | Biotechnology | Investor Relations Contact | |
| Sarcoma Foundation of America | Investment Trusts/Mutual Funds | Founder | |
| TSCAN THERAPEUTICS, INC. | Biotechnology | Director/Board Member | |
| London South Bank University | College/University | Undergraduate Degree | |
Notch Therapeutics, Inc.
 Notch Therapeutics, Inc. Pharmaceuticals: OtherHealth Technology Notch Therapeutics, Inc. engages in the development of cell therapies for the treatment of diseases. It offers technology platform, which uses genetically tailored stem cells as a renewable source for creating allogeneic T cell therapies that expand treatment options and deliver cell immunotherapies to patients. The company was founded by Juan Carlos Zuniga-Pflucker and Peter Zandstra in 2018 and is headquartered in Toronto, Canada. | Pharmaceuticals: Other | Director/Board Member | |
Bayer HealthCare Pharmaceuticals, Inc.
 Bayer HealthCare Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Bayer HealthCare Pharmaceuticals, Inc. manufactures pharmaceutical drugs. It offers pharmaceuticals and therapeutics in the areas of diagnostic imaging, hematology and cardiology, cancer, women's health and several other chronic diseases such as multiple sclerosis and Parkinson's disease. Bayer HealthCare Pharmaceuticals was founded in 1979 and is located in Wayne, NJ. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Vivelix Pharmaceuticals, Ltd.
 Vivelix Pharmaceuticals, Ltd. Pharmaceuticals: MajorHealth Technology Vivelix Pharmaceuticals, Ltd. manufactures and sells pharmaceutical products. The private company is based in Hamilton, BM. and has subsidiaries in the United States. The Bermudian company was founded by William P. Forbes. | Pharmaceuticals: Major | Director/Board Member | |
| ACADIA PHARMACEUTICALS INC. | Pharmaceuticals: Major | Chairman | |
| Rochester Christian University | College/University | Undergraduate Degree | |
| EXACT SCIENCES CORPORATION | Medical Specialties | Corporate Officer/Principal | |
| CASTLE BIOSCIENCES, INC. | Medical Specialties | Director/Board Member | |
Applied Biosystems, Inc.
 Applied Biosystems, Inc. Medical SpecialtiesHealth Technology Applied Biosystems, Inc. is a company that provides integrated systems for sequencing, flow cytometry, and various types of PCR. The company is based in Foster City, CA. The company's products cover the entire process from sample preparation to data analysis. The company was founded by Chris Yoo, Marvin H. Caruthers, Michael W. Hunkapiller, and Leroy E. Hood. Applied Biosystems was acquired by Invitrogen Corp. from Applera Corp. on November 21, 2008 for $6,417.85 million. | Medical Specialties | Director of Finance/CFO | |
EndoVascular Technologies, Inc.
 EndoVascular Technologies, Inc. Medical SpecialtiesHealth Technology Part of Boston Scientific Corp., EndoVascular Technologies, Inc. is a company that makes invasive endovascular systems. The company is based in Menlo Park, CA. The company was founded by Wesley D. Sterman. EndoVascular Technologies was acquired by Guidant Corp. on December 22, 1997 for $145.32 million. | Medical Specialties | Director of Finance/CFO | |
| San Jose State University | College/University | Masters Business Admin | |
| MERCK & CO., INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| IMMUNOGEN, INC. | Biotechnology | Director/Board Member | |
Pennsylvania Hospital
 Pennsylvania Hospital Hospital/Nursing ManagementHealth Services Pennsylvania Hospital provides healthcare services. It offers diagnostic and therapeutic medical services. The firm also offers general and specialty surgical services such as orthopedics, vascular medicine, neurosurgery, urology, neonatology, neurosciences, and behavioral health. The company was founded by Benjamin Franklin and Thomas Bond in 1751 and is headquartered in Philadelphia, PA. | Hospital/Nursing Management | Corporate Officer/Principal | |
| TCR2 THERAPEUTICS INC. | Pharmaceuticals: Major | Investor Relations Contact | |
| ARIAD PHARMACEUTICALS, INC. | Biotechnology | Compliance Officer | |
| BLUEBIRD BIO, INC. | Biotechnology | Compliance Officer | |
| VERASTEM, INC. | Biotechnology | General Counsel |
Statistiques
Internationale
| Etats-Unis | 45 |
| Canada | 3 |
| Royaume-Uni | 3 |
| Bermudes | 2 |
Sectorielle
| Health Technology | 37 |
| Consumer Services | 9 |
| Health Services | 3 |
| Finance | 2 |
| Commercial Services | 2 |
Opérationnelle
| Director/Board Member | 91 |
| Independent Dir/Board Member | 41 |
| Corporate Officer/Principal | 40 |
| Undergraduate Degree | 17 |
| Investor Relations Contact | 10 |
Relations les plus connectées
| Insiders | |
|---|---|
| Felix Baker | 28 |
| Kim Popovits | 19 |
| Thomas Malley | 17 |
| Richard Levy | 16 |
| Barry Quart | 12 |
| Stephen Biggar | 12 |
| G. Cole | 10 |
| Sanj Patel | 10 |
| Paul Cox | 9 |
| John Paolini | 9 |
| Tracey McCain | 8 |
| Eben Tessari | 6 |
| Madelyn Zeylikman | 6 |
| Mark Ragosa | 5 |
| Melissa Manno | 4 |
- Bourse
- Insiders
- Rachel Frank
- Connexions Sociétés
